Octreotide acetate Recalls

3 recalls found for Octreotide acetate. Check if any of your products are affected.

HIGHFDA DRUG

Teva Octreotide Acetate Injectable Suspension Recall 21,930 Cartons Over Sterility Risk (2026)

Teva Pharmaceuticals recalled 21,930 cartons of Octreotide Acetate for Injectable Suspension distributed nationwide in the United States. The recall stems from lack of assurance of sterility identified during an FDA inspection at the contract manufacturer. Healthcare providers and patients should stop using this product immediately and contact Teva or a physician for guidance.

OCTREOTIDE ACETATE
Lack of
Read more
HIGHFDA DRUG

Teva Octreotide Acetate Injectable Suspension Recall 19,869 Cartons Nationwide (2026)

Teva Pharmaceuticals USA recalled 19,869 cartons of Octreotide Acetate for Injectable Suspension nationwide in the United States after FDA inspection flagged lack of assurance of sterility at the contract manufacturer. The FDA cited quality system deficiencies at Pharmathen International S.A. in Greece. Healthcare providers and patients should stop using the product immediately and contact Teva or

OCTREOTIDE ACETATE
Lack of
Read more
HIGHFDA DRUG

Teva Octreotide Acetate Injectable Suspension Recall Expanded in 2026 for Sterility Concerns

Teva Pharmaceuticals recalled 1,897 cartons of Octreotide Acetate for Injectable Suspension distributed nationwide in the USA after an FDA inspection flagged sterility concerns. The recall is due to lack of assurance of sterility from the contract manufacturer. Consumers and healthcare providers should stop using the product immediately and contact Teva for guidance.

OCTREOTIDE ACETATE
Lack of
Read more

Brand Statistics

Total Recalls
3
Pages
1

Related Brands

Teva Pharmaceuticals, Inc.